IGS GeboJagema
IGS GeboJagema specialises in the development, manufacturing and validation of high-end multi-cavity injection moulds used worldwide for the production of medical devices (including contact lenses, inhalers and insulin pens) by healthcare and pharmaceutical manufacturers. IGS (150 FTE) is based in Eindhoven (NL) and Peachtree City (US), where its engineering team and state-of-the-art production facilities are located.
IGS is a uniquely positioned niche market leader. We are impressed by the scalability and high level of automation of the state-of-art factory footprint coupled with the model-based product development process. The company’s innovative character, focus on the medical sector, M&A opportunities and ambitions for further growth fit perfectly within the Smile Invest portfolio. Smile Invest has sold its majority position to BC Partners in 2025 and holds today a minority position.
Smile Invest team
“This transition comes at the right time, as we’re currently working on our entry into the United States. The medical sector has a zero-tolerance approach to risk. We offer high-quality, high-precision moulds and, together with our validation services, provide a one-stop solution. The partnership with Smile Invest offers us new possibilities, driven by their technological knowledge, international experience and network.”
